help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishida, M.
Right arrow Articles by Miyakawa, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishida, M.
Right arrow Articles by Miyakawa, I.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Endometriosis
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 10 5094-5100
Copyright © 2004 by The Endocrine Society

Down-Regulation of Interleukin-1 Receptor Type 1 Expression Causes the Dysregulated Expression of CXC Chemokines in Endometriotic Stromal Cells: A Possible Mechanism for the Altered Immunological Functions in Endometriosis

Masakazu Nishida, Kaei Nasu, Junichiro Fukuda, Yasushi Kawano, Hisashi Narahara and Isao Miyakawa

Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita 879-5593, Japan

Address all correspondence and requests for reprints to: Dr. Masakazu Nishida, Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Hasama-machi, Oita 879-5593, Japan. E-mail: nishida{at}med.oita-u.ac.jp.

To evaluate the involvement of chemokines in the pathogenesis of endometriosis, we investigated the expression of CXC chemokines in cultured ovarian endometriotic cyst stromal cells (ECSC), endometrial stromal cells with endometriosis (ESCwE), and normal endometrial stromal cells (NESC). Using ELISA, TNF-{alpha} significantly enhanced the production of IL-8, growth-related oncogene {alpha}, and epithelial neutrophil-activating peptide-78 in all cases of ECSC (n = 10), ESCwE (n = 6), and, NESC (n = 10). IL-1ß did not affect the production of these chemokines in eight of 10 cases of ECSC. In contrast, IL-1ß significantly enhanced the expression of these chemokines in all cases of ESCwE (n = 6) and NESC (n = 10). Western blot analysis revealed down-regulation of expression of IL-1 receptor type 1 (IL-1-R1) in all cases of ECSC with low response to IL-1ß (n = 8). In contrast, significant IL-1-R1 expression was detected in all cases of NESC. Although IL-1-R1 expression was detected in all cases of ESCwE (n = 6), its expression in ESCwE tended to decrease compared with that in NESC. Moreover, phosphorylation of inhibitor {kappa}B-{alpha} was detected in all cases of ESCwE and NESC after stimulation with IL-1ß, but not in ECSC with low response to IL-1ß (n = 8). In contrast, significant IL-1-R2 expression was detected in all cases of ECSC, ESCwE, and NESC. The present findings suggest that the dysregulation of IL-1/IL-1-R system relates to immunological dysfunction in endometriosis. The alteration of the CXC chemokines expression may be important for elucidation of the pathogenesis of endometriosis.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. Tsuno, K. Nasu, A. Yuge, H. Matsumoto, M. Nishida, and H. Narahara
Decidualization Attenuates the Contractility of Eutopic and Ectopic Endometrial Stromal Cells: Implications for Hormone Therapy of Endometriosis
J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2516 - 2523.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Chen, R. J. Belton Jr., and R. A. Nowak
Basigin-Mediated Gene Expression Changes in Mouse Uterine Stromal Cells During Implantation
Endocrinology, February 1, 2009; 150(2): 966 - 976.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Nasu, M. Nishida, T. Ueda, A. Yuge, N. Takai, and H. Narahara
Application of the nuclear factor-{kappa}B inhibitor BAY 11-7085 for the treatment of endometriosis: an in vitro study
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E16 - E23.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Yuge, K. Nasu, H. Matsumoto, M. Nishida, and H. Narahara
Collagen gel contractility is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis-associated fibrosis
Hum. Reprod., April 1, 2007; 22(4): 938 - 944.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Nishida, K. Nasu, T. Ueda, A. Yuge, N. Takai, and H. Narahara
beta-Hydroxyisovalerylshikonin induces apoptosis and G0/G1 cell-cycle arrest of endometriotic stromal cells: a preliminary in vitro study
Hum. Reprod., November 1, 2006; 21(11): 2850 - 2856.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Nasu, M. Nishida, T. Ueda, N. Takai, S. Bing, H. Narahara, and I. Miyakawa
Bufalin induces apoptosis and the G0/G1 cell cycle arrest of endometriotic stromal cells: a promising agent for the treatment of endometriosis
Mol. Hum. Reprod., November 1, 2005; 11(11): 817 - 823.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Nishida, K. Nasu, T. Ueda, J. Fukuda, N. Takai, and I. Miyakawa
Endometriotic cells are resistant to interferon-{gamma}-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis
Mol. Hum. Reprod., January 1, 2005; 11(1): 29 - 34.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society